InsidersTradesSigma
Track the 케이엠제약 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Banks sector, 케이엠제약 has logged 16 public disclosures. Market capitalisation: €9.7bn. The latest transaction was disclosed on 1 July 2026 (Purchase). Among the most active insiders: 강일모. All data is accessible without an account.
16
Insider Decl.
n/a
Thresholds
€72,799
14 ops.
Buy Volume
n/a
1 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,179 of 29,062 companies
12.5
score / 100
Value6
Quality19
FCF yld-27%
Earn yld-53%
EV/EBITDA·
ROE-13%
Gross mgn24%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 July 2026
Declarations16 total
373,936 sharesShareKRXDART:20260610000276
10,000 shares@ ₩519.51590.0000% mcap22.8% of flowShareKRXDART:20260421000222
23,111 shares@ ₩650.66570.0001% mcap66.8% of flowShareKRXDART:20260409001498
5,994 shares@ ₩390.88740.0000% mcap10.4% of flowShareKRXDART:20260313000274
16 of 16 declarations
Acerca de 케이엠제약
케이엠제약 es una empresa del sector de finanzas y banca, que cotiza en la bolsa XKRX.